Jordan, C. J., Humburg, B. A., Thorndike, E. B., Shaik, A. B., Xi, Z., Baumann, M. H., . . . Schindler, C. W. (2019). Newly Developed Dopamine D(3) Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats. J Pharmacol Exp Ther.

Jordan, Chloe J., Bree A. Humburg, Eric B. Thorndike, Anver Basha Shaik, Zheng-Xiong Xi, Michael H. Baumann, Amy Hauck Newman, and Charles W. Schindler. "Newly Developed Dopamine D(3) Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats." J Pharmacol Exp Ther 2019.

Jordan, Chloe J., et al. "Newly Developed Dopamine D(3) Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats." J Pharmacol Exp Ther 2019.